Marker Therapeutics, Inc. (MRKR)
1.34
+0.02
(+1.52%)
USD |
NASDAQ |
Mar 20, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Marker Therapeutics EPS Diluted (Quarterly) : -0.1022 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | -1.080 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Kiniksa Pharmaceuticals International Plc | 0.1741 |
| electroCore, Inc. | -0.3792 |
| Agenus, Inc. | -0.301 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.703M |
| Revenue (Quarterly) | 1.103M |
| Total Expenses (Quarterly) | 2.807M |
| Enterprise Value | 5.299M |
| Profit Margin (Quarterly) | -154.4% |
| Earnings Yield | -67.87% |
| Normalized Earnings Yield | -67.87 |